Castle Biosciences Inc
CSTL· Nasdaq
CSTLCastle Biosciences Inc
Filed Mar 10, 2020 · 10-K · 70 days after period end · 0001447362-20-000029
| Metric | Q4 2019 | Q4 2018 |
|---|---|---|
| Revenue | $17.64M | $11.44M |
| Net Income | $2.06M | $3.87M |
| EPS Diluted | $0.11 | $0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 10, 2020 · 70 d after period end
